Table 1.
Diagnosis criteria of metabolic syndrome used in current study
| MetS component | Modified ATP III criteria | IDF criteria | Harmonised definition |
|---|---|---|---|
| Number of risk factors | Three or more of… | Obesity and 2 of… | Three or more of… |
| Obesity | WC ≥90 cm for Asian-origin male WC ≥80 cm for Asian-origin female |
WC ≥90 cm for Chinese male WC ≥80 cm for Chinese female |
WC ≥85 cm for Chinese male WC ≥80 cm for Chinese female |
| Dyslipidaemia | |||
| TAG | ≥1·7 mmol/l or drug treatment for elevated TAG | ≥1·7 mmol/l or specific treatment for this lipid abnormality | ≥1·7 mmol/l or drug treatment for elevated TAG |
| HDL | <1·03 mmol/l in men or <1·29 mmol/l in women or drug treatment for reduced HDL-cholesterol | <1·03 mmol/l in men or <1·29 mmol/l in women or specific treatment for this lipid abnormality | <1·03 mmol/l in men or <1·29 mmol/l in women or drug treatment for reduced HDL-cholesterol |
| Blood pressure | SBP ≥130 mmHg or/and DBP ≥85 mmHg or drug treatment for hypertension | SBP ≥130 mmHg or/and DBP ≥85 mmHg or treatment of previously diagnosed hypertension | SBP ≥130 mmHg or/and DBP ≥85 mmHg or drug treatment for hypertension |
| Hyperglycaemia | FBG ≥5·6 mmol/l or drug treatment for elevated glucose | FBG ≥5·6 mmol/l or previously diagnosed T2DM | ≥5·6 mmol/l or drug treatment for elevated glucose |
SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.